Elanco Animal Health (ELAN) Tops Q3 EPS by 6c, Beats on Revenue; Offers FY25 Guidance

Elanco Animal Health Reports Third Quarter 2025 Results

November 5, 2025 6:27 AM EST

Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target

Third Quarter 2025 Financial Results: Revenue of $1,137 million, an increase of 10% year-over-year; 9% organic constant currency growth Reported Net Loss of $34 million, Adjusted Net Income of $94 million Adjusted EBITDA of $198 million; Adjusted EBITDA Margin of 17.5%  Reported EPS of $(0.07), Adjusted EPS of $0.19 Net leverage ratio of 3.7x Adjusted EBITDA Full Year 2025 Guidance: Raising revenue guidance to $4,645 million to $4,670 million; expect accelerating organic constant currency revenue growth of 6% to... More